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abstract
 
By deﬁning functional defects in a congenital myasthenic syndrome (CMS), we show that two mutant
residues, located in a binding site region of the acetylcholine receptor (AChR) epsilon subunit, exert opposite ef-
fects on ACh binding and suppress channel gating. Single channel kinetic analysis reveals that the ﬁrst mutation,
 
 
 
N182Y, increases ACh afﬁnity for receptors in the resting closed state, which promotes sequential occupancy of the
binding sites and discloses rate constants for ACh occupancy of the nonmutant 
 
  
 
 site. Studies of the analogous
mutation in the 
 
 
 
 subunit, 
 
 
 
N187Y, disclose rate constants for ACh occupancy of the nonmutant 
 
  
 
 site. The second
CMS mutation, 
 
 
 
D175N, reduces ACh afﬁnity for receptors in the resting closed state; occupancy of the mutant site
still promotes gating because a large difference in afﬁnity is maintained between closed and open states. 
 
 
 
D175N
impairs overall gating, however, through an effect independent of ACh occupancy. When mapped on a structural
model of the AChR binding site, 
 
 
 
N182Y localizes to the interface with the 
 
 
 
 subunit, and 
 
 
 
D175 to the entrance of
the ACh binding cavity. Both 
 
 
 
N182Y and 
 
 
 
D175 show state speciﬁcity in affecting closed relative to desensitized
state afﬁnities, suggesting that the protein chain harboring 
 
 
 
N182 and 
 
 
 
D175 rearranges in the course of receptor
desensitization. The overall results show that key residues at the ACh binding site differentially stabilize the agonist
bound to closed, open and desensitized states, and provide a set point for gating of the channel.
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INTRODUCTION
 
Nicotinic acetylcholine receptors (AChRs)* and their
relatives mediate synaptic transmission in the periph-
eral and central nervous systems. They are pentamers
in which each subunit contributes to a large extracellu-
lar domain as well as to an assembly of transmembrane
domains. AChRs belong to the ionotropic class of re-
ceptors and function as allosteric proteins that bind ag-
onist and transduce binding free energy into opening
and closing of the receptor ion channel (Changeux,
1990). Over the past decade studies of site-directed as
well as naturally occurring mutations have related key
residues in the AChR to their elementary functions.
The initial step in receptor function, ACh binding, is
accomplished by specialized residues at interfaces be-
tween 
 
 
 
-epsilon and 
 
 
 
-delta subunits of the adult mus-
cle AChR (Prince and Sine, 1998). Located in the large
extracellular domain, the interface residues provide re-
ceptors in the resting state with sufﬁcient afﬁnity to
bind synaptically released ACh, and endow the active
receptor with increased afﬁnity necessary to promote
high activity (Jackson, 1989). Our current picture of
the ACh binding site views these key residues purely as
sensors for ACh, promoting channel gating through
the large difference in afﬁnity between resting and ac-
tive states. However, because the binding site also serves
as a trigger for opening the channel, key residues at
the binding site may stabilize resting relative to active
states independently of ACh occupancy. Previous work
showed that mutations of residues at the binding site af-
fect both agonist binding and channel gating steps
(Chen et al., 1995, Ohno et al., 1996; Akk et al., 1999;
Akk, 2001), but effects on gating independent of ago-
nist binding have not been documented.
Congenital myasthenic syndromes (CMSs) are pre-
synaptic, synaptic, or postsynaptic in origin (Engel et
al., 1998). The postsynaptic CMS reported to date are
caused by mutations in subunits of the AChR that re-
duce expression or alter the kinetic properties of the
receptor. Two major types of kinetic mutations and
associated diseases have emerged: slow-channel syn-
drome mutations that enhance agonist afﬁnity or gat-
ing efﬁciency, and fast-channel syndrome mutations
that reduce agonist afﬁnity for the open channel or im-
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pair gating. Investigations of the molecular basis of
these syndromes have uncovered novel structures key
to AChR function (Engel et al., 1998).
The present study arose from analysis of a fast-channel
CMS deﬁned by clinical, electrophysiological and elec-
tron microscopic criteria, which prompted us to search
for mutations in AChR subunits and delineate their
mechanistic consequences. We trace the cause of the
CMS to two heteroallelic mutations in a region of the ep-
silon subunit that contributes to the ACh binding site,
and show that the CMS results from an attenuated
postsynaptic response. Kinetic analysis of engineered
mutant receptors reveals that the two mutations exert
opposing effects on ACh binding, but each mutation im-
pairs gating of the ion channel. The overall results sug-
gest that key residues in the ACh binding site contribute
locally to stabilize bound ACh and globally to stabilize
the closed relative to the open state of the channel.
 
MATERIALS AND METHODS
 
Endplate Studies
 
Intercostal muscle specimens were obtained intact from origin to
insertion from the patient and from control subjects without
muscle disease undergoing thoracic surgery. All human studies
were in accord with the guidelines of the Institutional Review
Board of the Mayo Clinic. Endplates (EPs) were localized for
electron microscopy by established methods (Engel, 1994).
 
 
 
-Bungarotoxin (
 
 
 
-Bgt) labeled with peroxidase was used for the
ultrastructural localization of AChR (Engel et al., 1977). The
number of AChRs per EP was measured with 
 
125
 
I-labeled 
 
 
 
-bgt, as
described previously (Engel et al., 1993).
Miniature EP potential (MEPP), miniature EP current (MEPC),
and EP potential recordings, and estimates of the number of
transmitter quanta released by nerve impulse were performed as
described previously (Engel et al., 1993; Uchitel et al., 1993).
Patch-clamp recordings from EP AChRs were performed in
cell-attached mode by a slight modiﬁcation of the previously
described method (Milone et al., 1994). For all patches, the
membrane potential was set to 
 
 
 
80 mV. Whenever possible, re-
cordings were also obtained at 
 
 
 
40, 
 
 
 
120, and 
 
 
 
160 mV. These
membrane potentials were achieved by applying a corresponding
potential to the patch pipette and assuming a resting potential of
0 mV. A null resting potential was conﬁrmed by the absence of
detectable channel events with 0 mV applied to the pipette.
Channel currents were recorded using an Axopatch 200A ampli-
ﬁer (Axon Instruments, Inc.) and analyzed at a ﬁnal bandwidth
of 8 kHz (patient EPs) and 12 kHz (control EPs) using the pro-
grams PClamp 6 (Axon Instruments, Inc.). Burst durations were
determined by grouping openings separated by a speciﬁed
closed time that misclassiﬁes equal proportions of long closed
times within bursts and short intervals between bursts (Colqu-
houn and Sakmann, 1985). Dwell time histograms were plotted
on a logarithmic abscissa and ﬁtted to the sum of exponentials by
maximum likelihood (Sigworth and Sine, 1987).
 
Mutation Analysis
 
We directly sequenced the AChR 
 
 
 
, 
 
 
 
, 
 
 
 
, and 
 
 
 
 subunit genes us-
ing genomic DNA isolated from blood (Ohno et al., 1995). To in-
vestigate family members, we traced 
 
 
 
D175N with allele-speciﬁc
PCR and 
 
 
 
N182Y by RsaI restriction analysis of PCR products.
 
 
 
N182Y results in gain of an RsaI site. To prove that the patient’s
two mutations are heteroallelic, we selectively ampliﬁed the al-
leles with and without 
 
 
 
D175N using mutant and wild-type allele-
speciﬁc PCR primers, respectively, and digested the products
with RsaI that recognizes only the 
 
 
 
N182Y allele. To exclude that
 
 
 
D175N and 
 
 
 
N182Y represent polymorphisms, we screened for
them in 200 normal alleles using allele-speciﬁc PCR. To check
paternity, we determined the numbers of tri- or tetranucleotide
repeats at D17S969, D17S918, and D17S2196 by direct sequenc-
ing. The paternity index was calculated using a Bayesian ap-
proach (Sozer et al., 2001).
 
Construction and Expression of Wild-Type and
Mutant AChRs
 
Human AChR 
 
 
 
, 
 
 
 
, 
 
 
 
, and 
 
 
 
 subunit cDNA were cloned into the
CMV-based expression vector pRBG4 as described elsewhere
(Ohno et al., 1996). 
 
 
 
D175N and 
 
 
 
N182Y were introduced into
the 
 
 
 
 subunit cDNA in pRBG4 by the QuickChange site-directed
mutagenesis kit (Stratagene). The presence of the desired muta-
tions and absence of unwanted artifacts were conﬁrmed by se-
quencing the entire insert. HEK 293 cells were transfected with
AChR subunit cDNAs using calcium phosphate precipitation
(Sine et al., 1995; Ohno et al., 1996). In some experiments the
BOSC cell line was used, which is a variant of the 293 HEK cell
line (Wang et al., 2000).
 
Patch-clamp Recordings from AChRs Expressed in HEK Cells
 
Recordings were obtained in the cell-attached conﬁguration at a
membrane potential of 
 
 
 
70 mV and at 22
 
 
 
C. The bath and pi-
pette solutions contained (mM): KCl 142, NaCl 5.4, CaCl
 
2
 
 1.8,
MgCl
 
2
 
 1.7, HEPES 10, pH 7.4. Single channel currents were re-
corded using an Axopatch 200A ampliﬁer at a bandwidth of 50
kHz, digitized at 5-
 
 
 
s intervals using an ITC-16 AD interface (In-
strutech), recorded to hard disk using the program Acquire, and
detected by the half-amplitude threshold criterion using the pro-
gram Tac (Bruxton Corporation) at a ﬁnal bandwidth of 10 kHz
(Wang et al., 1999). To estimate rate constants in Scheme I (see
text and Table III), clusters of events corresponding to a single
channel were identiﬁed as a series of closely spaced openings
preceded and followed by closed intervals greater than a speci-
ﬁed critical time; this time was taken as the point of intersection
of the predominant closed time component and the succeeding
closed time component. Each recording was examined for ho-
mogeneity by determining the mean open probability and open
duration for each cluster, and accepting clusters with parameters
within two standard deviations of the means (Ohno et al., 1996;
Wang et al., 1997). These selections included 
 
 
 
90% of the total
clusters. The resulting table of open and closed intervals were
transferred to a Dell Precision 610 work station, and analyzed ac-
cording to Scheme I using the program MIL (Qin et al., 1996),
which uses an interval-based maximum likelihood method that
corrects for missed events. A uniform ﬁlter bandwidth of 10 kHz
and a dead time of 23 
 
 
 
s were imposed for all recordings. For
each type of receptor, single channel dwell times, obtained at sev-
eral concentrations of ACh, were ﬁtted simultaneously. For wild-
type AChR, data were obtained at 3, 5, 10, 30, 50, 100, and 300
 
 
 
M ACh. For 
 
 
 
N182Y, 
 
 
 
N182F, and 
 
 
 
N182D data were obtained
at 1, 3, 10, 30, 100, and 300 
 
 
 
M ACh. For 
 
 
 
D175N data were ob-
tained at 10, 30, 100, 300, and 1,000 
 
 
 
M ACh. An average of
 
 
 
6,000 dwell times were analyzed for each ACh concentration,
with the range from 2,300 to 17,000. After ﬁtting, error estimates
were determined for each parameter (Qin et al., 1996). Theoret-
ical open and closed duration histograms were calculated from
the ﬁtted rate constants and superimposed on the experimental
dwell time histograms. To check the ﬁnal set of ﬁtted rate con- 
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stants, we used the method of Clay and DeFelice (1983) to simu-
late open and closed intervals according to Scheme I modiﬁed to
include short, intermediate, and long desensitized states to
mimic real data. The desensitized states were connected to the
doubly liganded closed state with forward rate constants of 200
s
 
 
 
1
 
 and backward rate constants of 200, 20, and 2 s
 
 
 
1
 
 to approxi-
mate the three desensitized states present in the data. After de-
ﬁning the critical closed time as described above, clusters were
identiﬁed, events briefer than the experimental dead time were
removed, and the resulting dwell times were ﬁtted with the pro-
gram MIL. In all cases the original rate constants were recovered
to within 10% of the original rate constants.
 
 
 
-Bgt and ACh Binding Measurements
 
The total number of 
 
125
 
I 
 
 
 
-bgt sites on the cell surface of transfected
HEK cells and ACh competition against the initial rate of 
 
125
 
I 
 
 
 
-bgt
were determined as previously described (Ohno et al., 1996). ACh
competition measurements were analyzed according to either the
Hill equation (Eq. 1) or the two binding site equation (Eq. 2):
 
(1)
(2)
 
where Y is fractional occupancy by ACh, n is the Hill coefﬁcient,
K
 
OV
 
 the overall dissociation constant, K
 
A
 
 the dissociation constant
for one site, and K
 
B
 
 the dissociation constant for the second site.
 
RESULTS
 
Characteristics of the CMS Patient
 
A 5-yr-old male had decreased movements in utero, eye-
lid ptosis since early infancy, and delayed motor develop-
ment. He fatigued rapidly on mild exertion and could
not keep up with his peers in physical activities. He had a
decremental electromyographic response on stimula-
tion of motor nerves, negative tests for anti-AChR anti-
bodies, and responded partially to cholinesterase inhibi-
tors. He has a high-arched palate, mild scoliosis, slight
limitation of the ocular ductions, and ﬂuctuating eyelid
ptosis. He can extend his arm horizontally for only 30 s.
The parents and a younger sibling are unaffected.
 
Endplate Studies
 
The conﬁguration of the EPs, evaluated from the cy-
tochemical reaction for acetylcholinesterase on 40 teased
single muscle ﬁbers, was normal on 33 ﬁbers and con-
sisted of 2–3 closely spaced small EP regions on 7 ﬁbers.
The number of 
 
125
 
I-
 
 
 
-bgt sites per EP was normal for the
patient’s age (Table I). The reaction for AChR at the EPs,
detected in cryostat sections with rhodamine-labeled
 
 
 
-bgt, was normal. Electron microscope studies of 45 EP
regions at 20 EPs revealed that the structural integrity of
the pre and postsynaptic regions was preserved, but 5 EP
regions had few or no secondary clefts and junctional
folds. The reaction for AChR on the junctional folds, de-
tected with peroxidase-labeled 
 
 
 
-bgt, was normal.
1Y – 1 1 ACh () KOV ⁄ [] + {}
n ⁄ =
1Y – fractA 1 1 ACh [] KA ⁄ + ⁄ ()
1 fractA – () 1 1 ACh [] KB ⁄ + ⁄ () ,
+ =
 
Quantal release by nerve impulse was normal. Al-
though the density and distribution of AChR on the
junctional folds appeared normal, the amplitude of the
MEPPs was reduced to 32%, and that of the MEPCs to
40% of normal. The MEPCs decayed abnormally fast,
so that 
 
 
 
MEPC
 
 was only 26% of normal (Table I).
To conﬁrm the kinetic defect of AChR predicted by the
rapidly decaying MEPCs, we compared single channel
currents recorded from control and patient EPs. In con-
trast to control EPs, only few channel openings could be
recorded from patient EPs with ACh concentrations
lower than 5 
 
 
 
M, suggesting a decreased probability of
channel opening. At patient EPs, 96% of all channel
openings had a normal conductance of 60 pS, but they
showed abnormally brief open durations; by contrast, 4%
(
 
 
 
1% at three EPs and 16% at one EP) of channel open-
ings had a conductance of 
 
 
 
44 pS and four- to ﬁvefold
longer than normal open durations, typical of fetal recep-
tors that harbor the 
 
 
 
 instead of the 
 
 
 
 subunit. Analysis of
the 60 pS channel events at patient and control EPs re-
solved two components both in bursts of openings and
single openings (
 
 
 
1
 
 and 
 
 
 
2
 
), but in the patient the briefer
component, 
 
 1, was dominant, whereas at control EPs the
longer component,  2, was dominant (Table II and Fig.
1). To summarize, EP studies revealed no AChR deﬁ-
TABLE I
Endplate Studies
Patient Controls
125I- -bgt binding sites/EP 5.5 E6 12.82   0.79 E6 (13 adults)
4.7 E6 (3-yr-old control)
EPP quantal content (1 Hz)a 34   4 (11) 31   1 (190)
MEPP amplitude (mV)b 0.32   0.069 (15) 1.00   0.025 (164)
MEPC amplitude (nA) 1.60   0.086 (14) 3.95   0.10 (79)
 MEPC 0.85   0.057 (14)  3.23   0.06
Values represent mean   SE. Numbers in parentheses indicate number of end-
plates, except for  -bgt binding sites where they indicate number of adult con-
trols. T   29   0.5 C for EPP and MEPP recordings, and 22   0.5 C for MEPC
studies.
aQuantal content of EP potential (EPP) at 1 Hz stimulation corrected for rest-
ing membrane potential of  80 mV, nonlinear summation, and non-Poisson
release.
bCorrected for resting membrane potential of  80 mV and a mean muscle ﬁ-
ber diameter of 55  m.
TABLE II
Open Intervals at Seven Control and Four Patient EPs
Open intervals Bursts
Controls Patient Controls Patient
 1 (ms) 0.07   0.02 0.17   0.021 0.09   0.03 0.17   0.025
area 0.14   0.04 0.65   0.19 0.13   0.02 0.61   0.061
 2 (ms) 1.13   0.10 0.51   0.037 2.99   0.26 0.59   0.061
area 0.86   0.04 0.34   0.096 0.87   0.02 0.39   0.061
Mean   SE. ACh   1  M for controls, 5  M for patient. Bandwidth   12 kHz
for controls, 8 kHz for patient. Membrane potential    80 mV, T   22  
0.5 C. 486 CMS Mutations Alter ACh Binding and Channel Gating
ciency, rapidly decaying MEPCs, abnormally brief chan-
nel openings, and a small population of fetal AChRs.
Mutation Analysis
To determine the basis of the observed kinetic abnor-
malities, we proceeded with mutation analysis. Direct
sequencing of all exons and ﬂanking regions of the
AChR  ,  ,  , and   subunit genes revealed two het-
erozygous mutations in the extracellular domain of
the AChR   subunit: a G-to-A substitution at nucle-
otide 523 in   exon 6, predicting an aspartate-to-aspar-
agine substitution at codon 175 ( D175N), and an
A-to-T substitution at nucleotide 544 in   exon 7, pre-
dicting an asparagine-to-tyrosine substitution at codon
182 ( N182Y). Aspartate at   codon 175 is conserved
in the human  ,  , and   subunits, and in   subunits
of all species. Asparagine at   codon 182 is conserved
in the human  ,  , and   subunits, and in   subunits
of all species (Fig. 2 C). Neither  D175N nor  N182Y
was found in 200 normal alleles. Analysis of family
members showed that the asymptomatic mother and
brother are heterozygous for  N182Y, but no other
family member carries  D175N (Fig. 2 A). Combined
allele-speciﬁc PCR and RsaI restriction analysis re-
vealed that  D175N and  N182Y are heteroallelic in
the patient (Fig. 2 B). Although the father does not
carry  D175N, analysis of the D17S969, D17S918, and
D17S2196 markers in the parents revealed 90.6%
probability of paternity (unpublished data). Thus,
 D175N either arose in the paternal germline or was a
spontaneous mutation.
Activation of Wild-Type,  D175N, and  N182Y Receptors
in Transfected Cells
To establish that  N182Y and  D175N cause the fast-chan-
nel CMS, we recorded single channel currents from 293
human embryonic kidney (293 HEK) cells transfected
with wild-type  ,  , and   plus either wild-type or mutant  
subunit cDNAs. For each wild-type or mutant receptor, we
applied a range of high concentrations of ACh (1–1000
 M) to elicit clustering of the currents into epochs during
which only one channel is active. Recording individual
clusters of channel activity allows subsequent removal of
intercluster closed periods due to desensitization, allow-
ing analysis of receptor activation independent of desensi-
tization (Sine et al., 1990). Inspection of current pulses
within clusters reveals briefer openings and prolonged
closings for both  N182Y and  D175N receptors com-
pared with wild-type receptors (Fig. 3). The briefer open-
ings of the two mutant receptors mirror the briefer single
channel currents and faster decays of MEPCs recorded at
patient EPs. Thus,  N182Yand  D175N together cause the
fast-channel CMS.
Elementary Kinetic Steps Altered by  D175N and  N182Y
To uncover the mechanistic consequences of  N182Y
and   D175N, we constructed dwell time histograms
from open and closed intervals within individual clus-
ters of single channel activity (see materials and
methods). Histograms of open dwell times show a ma-
jor peak, or exponential component at all ACh concen-
trations (Fig. 3). A second brief component, visible as a
rise in the distribution to the left of the major compo-
nent, is present at low but not high ACh concentra-
tions. The second component is readily discerned in
the data for wild-type and  D175N receptors selected
for display. However, because the  N182Y mutation in-
creases agonist afﬁnity, as described below, the second
component is present only at ACh concentrations  10
 M (unpublished data). Histograms of closed dwell
times show two predominant components, the longer
of which moves to briefer time as the ACh concentra-
Figure 1. AChR channel currents re-
corded from control and patient EPs.
Left column shows AChR channel cur-
rents elicited by 1  M ACh from con-
trol EP and by 5  M ACh elicited from
patient EP, with openings as upward de-
ﬂections. Channel opening events are
briefer at patient than at control EP.
Right column shows the corresponding
burst duration histograms with dotted
lines indicating burst components.
Time constants,  n, and fractional areas,
an, for each component of bursts: Con-
trol:  1   0.04 ms, a1   0.09,  2   2.38
ms; a2   0.91, total events, 1,315. Pa-
tient:  1   0.185, a1   0.67,  2   0.66
ms, a2   0.33; total events, 4,025. Band-
width   12 kHz for control, 8 kHz for
patient; membrane potential     80
mV, T   22 C   0.5.487 Sine et al.
tion increases. These concentration dependencies of
open and closed dwell times are observed for wild-type
and each mutant AChR, and are characteristic of an ac-
tivation process driven by ACh concentration.
To identify elementary kinetic steps altered by  N182Y
and  D175N, we analyzed the closed and open dwell
times according to the following standard description
of receptor activation,
where A is the agonist, R is the closed receptor, R* is
the open receptor, k 1 and k 2 are association rate con-
SCHEME I
stants, and k 1 and k 2 are dissociation rate constants.
Singly occupied receptors AR open with rate constant
 1 and close with rate constant  1, whereas doubly oc-
cupied receptors A2R open with rate constant  2 and
close with rate constant  2. A blocked state A2RB is in-
cluded to account for brief channel closures elicited by
high ACh concentrations.
We estimated rate constants for each state transi-
tion in Scheme I by computing the likelihood of the
experimental series of dwell times, given a set of trial
rate constants, and then changing the rate constants
to maximize the likelihood (see materials and
methods). For wild-type and each mutant receptor,
we ﬁtted Scheme I simultaneously to open and
closed dwell times obtained for the entire range of
ACh concentrations. Use of a range of ACh concen-
trations optimizes the contribution of dwells in each
receptor state to the cumulative likelihood. The ﬁt-
ted rate constants yield probability density functions
that superimpose upon the open and closed dura-
tion histograms (Fig. 3), showing that Scheme I de-
scribes activation of wild-type,  N182Y, and  D175N
receptors.
Functional Consequences of the  N182Y Mutation
The ﬁtted rate constants show that  N182Y markedly
increases ACh afﬁnity for one of the two binding sites
in the resting closed state of the receptor, but does
not affect ACh afﬁnity for the second binding site (Ta-
ble III). The dissociation constant for the altered site
falls from 138  M for the wild-type receptor to 2  M
for the mutant, owing to a 30-fold slowing of the rate
constant for ACh dissociation and a twofold increase
of the rate constant for ACh association. Because the
mutation is present in the   subunit, the binding site
with increased ACh afﬁnity corresponds to the    site.
The increased afﬁnity conferred by  N182Y deﬁnes
the sequence in which ACh occupies the binding sites
of the mutant receptor in the course of opening the
channel; the    site is occupied ﬁrst, whereas the   
site is occupied second.
The  N182Y mutation not only alters ACh binding,
but it also alters gating of the channel. The gating
equilibrium constants for singly occupied ( 1) and
doubly occupied ( 2) receptors are reduced by an or-
der of magnitude. Reduction of  2 likely follows di-
rectly from the reduction in  1 because ACh occu-
pancy of the second binding site begins with a singly
occupied receptor less prone to opening. Thus, al-
though the second occupancy step in the mutant re-
ceptor promotes channel gating as well as the second
occupancy step in wild-type ( 2/ 1   1,080 for the mu-
tant and  2/ 1   1,083 for wild-type; see Table III),
gating of the doubly occupied mutant receptor is re-
duced by an order of magnitude.
Figure 2. (A) Allele-speciﬁc PCR (ASP) for  D175N and RsaI
restriction analysis for  N182Y of genomic DNA from patient (ar-
row) and family members. The patient carries  D175N and
 N182Y; patient, mother, and brother harbor  N182Y. Open and
closed arrowheads indicate wild-type and mutant fragments, re-
spectively. (B) The  D175N and  N182Y mutations are heteroal-
lelic. Allele-speciﬁc PCR selectively ampliﬁes the  D175N allele
(left), and the  D175N allele (right). PCR product ampliﬁed
from each allele is digested with RsaI that only cuts the  N182Y
allele. That only allele “b” is cut by RsaI indicates that  N182Y is
on allele “b”. (C) Aspartate at   codon 175 (D175) is conserved
in human  ,  , and   subunits, and in   subunits of all species. As-
paragine at   codon 182 (N182) is conserved in human  ,  , and
  subunits, and in   subunits of all species.488 CMS Mutations Alter ACh Binding and Channel Gating
Mechanistic underpinnings for the reduced  1 can be
understood by inspection of the following expanded
form of Scheme I (Monod et al., 1965):
where K1* and K2* are dissociation constants for ACh
binding to the open states and  0 is the gating equilib-
rium constant in the absence of agonist. According to
Scheme II,  1 could decrease due to (a) a decrease of K1
relative to K1* or (b) a decrease of  0 without a change in
K1 relative to K1*. Because neither K1* nor  0 are deﬁned
by the data, both alternatives are formal possibilities.
Comparison of ACh binding steps for wild-type and
 N182Y mutant receptors shows that the second bind-
SCHEME II
ing site in the  N182Y receptor is similar to the ﬁrst
binding site in the wild-type receptor; both the associa-
tion and dissociation rate constants are similar between
the two types of receptors (Table III). A common unal-
tered site is also observed for the site-directed muta-
tions  N182F and  N182D described below. The most
likely explanation for a common site is  N182Y affects
the    binding site without altering the    binding site.
Thus, mutations at  N182 not only reveal a new deter-
minant of ACh binding afﬁnity, but also provide inde-
pendent estimates of the rate constants underlying
ACh occupancy of the wild-type    site.
Structural Basis of the Effects of the  N182Y Mutation
To determine the structural basis for the effect of
 N182Y on receptor activation, we constructed mu-
tations with electron-rich side chains,  N182F and
 N182D, and examined single channel kinetics of the re-
sulting mutant receptors (Fig. 4). Mutation to phenylala-
nine mimics the effects of the original tyrosine mutation,
increasing ACh afﬁnity for one of the two binding sites
Figure 3. Kinetics of activa-
tion of wild-type and mutant re-
ceptors. Left column displays in-
dividual clusters of single chan-
nel currents recorded at the
indicated ACh concentrations
from cells expressing adult hu-
man AChRs containing the indi-
cated mutant   subunits. Cur-
rents are displayed at a band-
width of 10 kHz, with channel
openings shown as upward de-
ﬂections. Center and right col-
umns display the correspond-
ing closed and open duration
histograms with the ﬁts for
Scheme I superimposed. Fitted
rate constants are given in Ta-
ble III.489 Sine et al.
in the resting closed state and impairing gating of singly
and doubly occupied receptors (Table III). Mutation to
aspartic acid increases ACh afﬁnity of the mutant bind-
ing site similar to the original tyrosine mutation, but en-
hances rather than impairs channel gating (Table III).
For receptors containing either  N182F or  N182D, rate
constants underlying ACh binding to the nonmutant  – 
site are similar to those obtained for the nonmutant site
in the  N182Y receptor, and to one of the two sites in
wild-type AChR. Thus, as observed for  N182Y, both
 N182F and  N182D promote sequential occupancy by
ACh because they decrease K1 relative to K2 (Table III).
TABLE III
Fits of Scheme I to Dwell Times from Wild-Type and Mutant AChRs
Receptor k 1 k 1 K1 k 2 k 2 K2  1  1  1  2  2  2 k b k b KB
 M  M  M  M  M  M mM mM  mM 
Wild-type 197   14 5,180   450 26 120   4 16,600   290 138 99   10 4,070   470 0.024 47,000   1,200 1,800   45 26 36   5 139,000   6,000 3.9
Wild-type constraint 200 7,400 37 150   3 16,600   260 111 155   9 3,750   360 0.041 43,700   1,060 1,630   36 27 28   4 128,000   7,200 4.6
 N182Y 267   17 529   40 2.0 202   3 8,080   110 40 23   2 9,380   670 0.0025 8,340   100 3,110   17 2.7 17   5.8 130,000   1,400 7.6
 N182F 144   12 443   50 3.0 143   4 7,130   140 50 53   4 7,880   520 0.0067 6,860   100 3,350   23 2.1 18   9 123,000   2,600 6.8
 N182D 187   6 1,400   70 7.5 263   7 7,250   110 28 124   9 1,370   110 0.091 46,600   660 1,180   19 40 48   7 167,000   5,900 3.5
 N187Y 251   16 3,100   240 12 174   4 15,260   240 88 44   3 5,760   410 0.0076 15,240   240 2,590   20 5.9 11   1 81,500   5,600 7.4
 D175N 50.7   8 5,920   1,100 117 35   4 27,200   1,700 777 90   10 7,400   300 0.012 2,930   160 2,170   31 1.4 22   1.3 99,400   2,500 4.5
 D175N constraint 200 7,400 37 16   1 31,700   1500 1,980 30   1 9,600   420 0.0031 5,010   290 2,390   26 2.1 21   1 98,600   2,600 4.7
Receptor indicates the mutant subunit expressed with complementary wild-type subunits. Rate constants are as deﬁned in Scheme I, in units of  M 1 s 1 for association rate con-
stants, and s 1 for all others. Values are results of global ﬁts to data obtained over a range of ACh concentrations, with standard errors indicated by   (see materials and meth-
ods). The channel gating equilibrium constants,  , are ratios of the corresponding opening to closing rate constants,  / . Constraint indicates k 1 and k 1 were constrained to 
the average of values obtained for the low afﬁnity site in  N182Y,  N182F, and  N182D receptors.
Figure 4. Kinetics of activation
of receptors with site-directed
mutations. Left column displays
individual clusters of single
channel currents recorded at
the indicated ACh concentra-
tions from cells expressing adult
human AChRs containing the
indicated mutant subunits, as in
Fig. 3.490 CMS Mutations Alter ACh Binding and Channel Gating
Unlike the tyrosine and phenylalanine mutations,
the aspartic acid mutation increases rather than de-
creases channel opening equilibrium constants for sin-
gly and doubly occupied receptors (Table III). The in-
creased  1 may owe to enhanced binding of ACh to the
open relative to the closed state of the mutant  –  site,
or to an effect of  N182D on gating of the channel in
the absence of ACh (see Scheme II above). However,
the increase of  2 is likely a direct consequence of the
increase of  1 because ACh occupancy of the second
binding site begins with a singly occupied receptor
more prone to opening. The overall results of side
chain substitutions indicate that the consequences of
the original mutation  N182Y owe to substitution of an
aromatic ring, and that electron density at this position
affects ACh afﬁnity for the resting closed state of the re-
ceptor. Altogether, analyses of the three mutations of
 N182 provide independent estimates of rate constants
underlying ACh binding to the nonmutant  –  site.
Studies of the Analogous  N187Y Mutation
We constructed the analogous mutation in the   sub-
unit,  N187Y, to determine whether it affects ACh bind-
ing to one of the two binding sites, as observed for
 N182Y, and to independently estimate rate constants
underlying ACh occupancy of the nonmutant    site.
Single channel currents and the corresponding ﬁtted
rate constants show that the  N187Y mutation enhances
ACh afﬁnity for one binding site in the resting closed
state, but does not affect ACh afﬁnity for the second site
(Fig. 4; Table III). The rate constant for ACh associa-
tion accelerates 1.3-fold, and the rate constant for ACh
dissociation slows 1.7-fold; the resulting dissociation
constant for the altered site falls from 26  M for wild-
type AChR to 12  M for the mutant. Because the muta-
tion is present in the   subunit, the binding site with in-
creased agonist afﬁnity corresponds to the    site.
Moreover, rate constants underlying ACh occupancy of
the nonmutant    site are very similar to those of the
low afﬁnity binding site in the wild-type receptor (Table
III). Thus, the  N182Y and  N187Y mutations locally af-
fect ACh afﬁnity of the corresponding    or    sites,
providing independent estimates of rate constants un-
derlying ACh binding to nonmutant    and    sites.
In the wild-type human AChR, the    subunit inter-
face forms the binding site with high afﬁnity for ACh,
whereas    interface forms the site with low afﬁnity.
Functional Consequences of  D175N
Single channel kinetic analysis of currents through re-
ceptors containing  D175N suggests that ACh binding
is impaired at both binding sites (Table III). However,
because the mutation is present in the   subunit,
we tested the idea that  D175N affects the afﬁnity of
only one binding site. A mutational effect restricted to
the    site is likely because four mutations,  N182Y,
 N182F,  N182D, and  N187Y, had local effects at the
corresponding  –  or  –  sites. Furthermore, the pro-
tein chain harboring  N182 and  D175 is not part of a
secondary structural element and lodges in a crevice on
the periphery of the subunit (Sine et al., 2002). Thus,
we constrained rate constants for one binding site to
the average of those obtained for the nonmutant  – 
site from analyses of the three mutations at  N182, and
allowed rate constants for the other binding site to vary.
The resulting ﬁts provided well-deﬁned rate constants
for both wild-type and  D175N receptors (Table III);
probability density functions computed from the ﬁtted
rate constants superimpose upon the dwell time histo-
grams for both types of receptors (Fig. 3), and were in-
distinguishable from those obtained from the uncon-
strained ﬁtting (not shown). Moreover, the resulting
ﬁtted parameters reveal that  D175N slows the rate
constant for ACh association  10-fold, and accelerates
the rate constant for ACh dissociation twofold; the mu-
tation increases the dissociation constant for ACh bind-
ing to the    site from 111 to 1,980  M (Table III).
The ﬁtting analysis also reveals that  D175N reduces
gating of singly and doubly occupied receptors by
about an order of magnitude (Table III). The gating
equilibrium constant  1 is particularly well discerned in
the data where a predominant brief component of
openings, present at low ACh concentrations, is re-
placed by a longer-lived component at high concentra-
tions (Fig. 3). The decrease of  2 is likely a direct conse-
quence of the decrease of  1 because binding of the
second ACh starts with a singly occupied receptor less
prone to opening. Thus, although ACh occupancy
of the mutant binding site promotes channel gating
nearly as well as occupancy of the second binding site
in wild-type ( 2/ 1     677 for  D175N and  2/ 1   
1,083 for wild-type), gating of the doubly occupied mu-
tant receptor is reduced by an order of magnitude.
The possibility that  D175N preferentially affects
ACh afﬁnity for the open relative to the closed state of
the receptor was assessed by applying detailed balanc-
ing to the following cycle taken from Scheme II:
Here K2* is the dissociation constant for agonist bind-
ing to the open state of the receptor, which equals
K2 1/ 2. For the wild-type receptor, K2* calculated from
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the present data is 168 nM, whereas K2* for the
 D175N mutant is 2,920 nM. Thus,  D175N increases
K2* by 17-fold, which is close to its 18-fold increase of
K2, indicating that the mutation does not preferentially
affect ACh afﬁnity for the open relative to the closed
state of the receptor.
If the  D175N mutation maintains a large K2/K2* ra-
tio, providing a normal increase of  2 relative to  1, how
does  D175N impair overall gating of the channel? The
earliest discernable effect in Scheme I is reduction of
 1, but this observation leads to the following paradox:
how does a mutation at the    site affect the gating
equilibrium constant associated with ACh occupancy of
the nonmutant    site? A likely explanation is that resi-
dues at the binding site not only mediate recognition
of ACh, but also set the trigger point for opening the
channel. Thus, the results suggest that residues at the
binding site may contribute to stability of closed rela-
tive to open states of the channel even when agonist is
not bound.
Mutational Effects on Channel Open Probability
To illustrate the overall consequences of  D175N,
 N182Y, and  N182D, and to conﬁrm our estimated
rate constants, we determined the fraction of receptors
activated as a function of ACh concentration, and com-
pared it with the dose–response relationship calculated
from the ﬁtted rate constants in Table III. Our measure
of the fraction of receptors activated is the mean open
probability (Popen) within identiﬁed clusters due to sin-
gle AChRs (see traces in Fig. 3). The  N182Y mutation
reduces the maximum channel open probability, but
does not signiﬁcantly shift the curve along the concen-
tration axis (Fig. 5). By contrast the engineered muta-
tion,  N182D, shifts the curve to the left and increases
the maximum channel open probability due to en-
hanced gating and increased afﬁnity of one of the two
binding sites. The  D175N mutation shifts the dose–
response curve far to the right and decreases the maxi-
mum channel open probability due to impaired gating
and reduced afﬁnity of one of the two binding sites.
The kinetically derived dose–response curves superim-
pose upon the Popen measurements, thus supporting
the rate constant estimates.
Effects of  D175N and  N182Y on ACh Binding to 
Desensitized AChRs
Our single channel kinetic analysis reveals that  N182Y
enhances, whereas  D175N reduces, ACh afﬁnity for
receptors in the resting closed state. To determine
whether these mutations affect ACh afﬁnity for recep-
tors in the desensitized state, we converted receptors to
the desensitized state using the local anesthetic proad-
ifen (Sine and Taylor, 1982), and then measured bind-
ing of ACh (Ohno et al., 1996). We incubated intact
293 HEK cells expressing recombinant receptors with
speciﬁed concentrations of ACh, with or without pro-
adifen, and then measured binding of ACh by compe-
tition against the initial rate of 125I- -bgt binding. For
the wild-type receptor, the presence of proadifen in-
creases ACh afﬁnity  100-fold due to high afﬁnity of
the desensitized state (Fig. 6). Binding of ACh to the
desensitized wild-type receptor is described by a two-
site model in which the ﬁtted dissociation constants
differ by three- to ﬁvefold, indicating slightly different
ACh afﬁnities of the two binding sites in the desensi-
tized state.
For receptors containing the  N182Y mutation, pro-
adifen also increases ACh afﬁnity, but the competition
curve closely approaches that of the wild-type receptor
in the presence of proadifen (Fig. 6 A); the desensi-
tized state afﬁnity for the  N182Y receptor is only 1.6-
fold greater than that of the wild-type receptor. Thus,
although   N182Y markedly increases agonist afﬁnity
for receptors in the resting closed state, it only slightly
increases agonist afﬁnity for receptors in the desensi-
tized state.
For receptors containing the  D175N mutation,
proadifen again increases ACh afﬁnity, but the binding
proﬁle shows two clear components (Fig. 6 B). The dis-
sociation constant for the high afﬁnity component of
the  D175N receptor (27 nM) coincides with that for
the low afﬁnity component of the wild-type receptor
(range: 29–33 nM; see Fig. 6, legend), indicating a
common unaltered site in the desensitized state, which
Figure 5. Dependence of channel open probability (Popen) on
ACh concentration for receptors containing the indicated mu-
tant   subunits plus complementary  ,  , and   subunits. The
mean fraction of time the channel was open during a cluster
(Popen) was determined at the indicated concentrations of ACh.
The theoretical Popen was calculated from Scheme I using the ﬁt-
ted rate constants in Table III, and superimposed on the Popen
measurements. Error bars indicate standard deviations of Popen
for the population of clusters at the speciﬁed ACh concentration.492 CMS Mutations Alter ACh Binding and Channel Gating
corresponds to the    site. On the other hand, the low
afﬁnity component (1,700 nM) for the  D175N recep-
tor is shifted some 800-fold to the right of the high af-
ﬁnity component for the wild-type receptor (range: 2–9
nM; see Fig. 6, legend), indicating a large decrease in
desensitized state afﬁnity at the    site. Thus, both
 N182Y and  D175N are state-speciﬁc in affecting ACh
afﬁnity;  N182Y increases closed state afﬁnity 70-fold
but only increases desensitized state afﬁnity 1.6-fold,
whereas  D175N decreases closed state afﬁnity 17-fold
but decreases desensitized state afﬁnity 800-fold.
DISCUSSION
The present work begins by deﬁning a CMS by clinical,
morphological, and in vitro electrophysiological crite-
ria, and then traces its cause to two heteroallelic muta-
tions, N182Y and D175N, in the AChR   subunit. Mech-
anistic analyses of AChR activation reveal that each mu-
tation reduces the magnitude and hastens the decay of
the postsynaptic response, classifying the CMS as a fast-
channel syndrome. The  D175N mutation reduces
ACh sensitivity of the resting closed state of the recep-
tor by slowing ACh association and speeding ACh disso-
ciation, whereas  N182Y enhances ACh sensitivity by
speeding ACh association and slowing ACh dissocia-
tion. For both mutations, the effects at the binding site
are accompanied by impaired gating of the channel
through a mechanism independent of agonist occu-
pancy of the mutant binding sites. The overall results
show that key residues at the ACh binding site contrib-
ute locally to stabilize ACh bound to closed and open
states, as well as contribute globally to provide a set
point for triggering gating of the channel. Our results
also demonstrate state-selective effects of the mutations
on resting relative to desensitized states. When mapped
on a structural model of the muscle AChR binding site
(Sine et al., 2002),  N182Y localizes to the subunit in-
terface with the   subunit and  D175N to the entrance
of the ACh binding site cavity.
The   D175N and  N182Y mutations compromise
neuromuscular transmission by reducing the ampli-
tude of the postsynaptic response and accelerating its
decay. Because the density and distribution of AChR on
the postsynaptic membrane was normal, we attribute
the reduced MEPP and MEPC amplitudes to the de-
creased probability that the fully occupied receptor will
open. Based on the rate constants in Table III, the
probability that a doubly liganded AChR opens in re-
sponse to an instantaneous transmitter pulse,  2/( 2  
k 2), is 0.74 for the wild-type receptor, but only 0.14 for
the   D175N receptor, and 0.51 for the  N182Y re-
ceptor.
The rate constants in Table III also predict burst
open durations, (1    2/k 2)/ 2, of 2.13 ms for wild-
type AChR, but only 0.49 for the  D175N receptor and
0.65 ms for the  182Y receptor. The predicted burst
open durations for either mutant receptor are in excel-
lent agreement with the 0.59 ms burst open duration
recorded from patient EPs (see Table II) that reﬂects
the approximate average of burst durations generated
by the two mutant species of EP AChRs. The burst open
duration observed in single channel patch-clamp re-
cordings from the EP is also an approximate measure
of the decay time constant of the MEPC. Concordant
with the observed burst open duration, the  MEPC was
0.85 ms at patient EPs (Table I).
The mutations identiﬁed here alter rate constants
underlying both ACh binding and gating of the chan-
nel. A natural way to interpret these ﬁndings would be
to identify a mechanism that links these two effects.
However, for the  D175N mutation, the effects at the
binding site in the resting closed state, slowing ACh as-
sociation and speeding ACh dissociation, do not impair
the ability of ACh occupancy to promote gating of the
channel. Instead, channel gating itself is impaired,
which is seen as reduced gating following ACh occu-
Figure 6. ACh binding to receptors in the presence of the de-
sensitizing agent proadifen. (A) Comparison of ACh binding to
wild-type and  N182Y receptors. (B) Comparison of ACh binding
to wild-type and  D175N receptors. Binding of ACh was deter-
mined by competition against the initial rate of 125I- -bgt bind-
ing. Intact HEK cells expressing the indicated receptor type were
incubated in the presence of ACh, with or without 100  M
proadifen (pro), 30 min before measuring the initial rate of
 -bgt binding. Smooth curves are ﬁts to the Hill equation (mea-
surements in the absence of proadifen) or to an equation de-
scribing the sum of two binding sites (measurements in the pres-
ence of proadifen). Fitted parameters (A): wild-type, Kov   7.9  
10 7, n   1.4; wild-type plus proadifen, KA   3.3   10 8, KB   2.1  
10 9;  N182Y, Kov   1.4   10 7, n   0.9;  N182Y plus proadifen,
KA   2.3   10 8, KB   1.2   10 9. Fitted parameters (B): wild-
type, Kov   1.5   10 6, n   1.1;  D175N, Kov   1.2   10 5, n  
1.1; wild-type plus proadifen, KA   2.9   10 8, KB   8.9   10 9;
 D175N plus proadifen, KA   2.7   10 8, KB   1.7   10 6.493 Sine et al.
pancy of the nonmutant    site. The possibility that the
 D175N mutation allosterically affects the nonmutant
   site seems unlikely because several mutations in the
local protein chain affect rate constants underlying
ACh occupancy at only one of the two binding sites.
The consequences of  D175N are best explained by the
idea that residues at the binding site not only mediate
recognition of ACh, but also set the trigger point for
opening the channel. Thus, both the structure of the
ACh binding site and the structure of the ion channel
contribute to stability of closed relative to open states of
the receptor. A further test of this idea might be to
compare channel opening in the absence of agonist for
wild-type and the  D175N mutation, but this would be
difﬁcult in practice because spontaneous opening is
rare and difﬁcult to quantify.
Similar to the  D175N mutation,  N182Y affects rate
constants underlying both ACh binding and channel
gating. Because  N182Y enhances ACh afﬁnity and in-
creases the rate constant for ACh binding to the closed
state of the receptor, occupancy of the    site becomes
the ﬁrst step in activating the mutant receptor. This
promotion of sequential occupancy means that only
two out of four equilibrium constants in the ﬁrst cycle
of Scheme II can be estimated for the mutant receptor.
Rate constants underlying ACh binding to the closed
state and opening of mono-liganded receptors are well
deﬁned by the measurements, but those for the cou-
pled steps, binding of the ﬁrst ACh to the open state
and opening of unliganded receptors, remain un-
known. Thus, we ﬁnd that monoliganded gating de-
creases following ACh occupancy of the mutant site,
but this could be due to either a change in closed rela-
tive to open state afﬁnity for ACh, or to a change in
spontaneous gating of the receptor.
Previous mutagenesis studies of the ACh binding site
revealed decreases in both ACh afﬁnity for receptors in
the resting closed state and impaired gating of the
channel. The traditional explanation of such dual
changes is state-speciﬁcity of the mutations; the muta-
tions alter closed relative to open state afﬁnities for
ACh, which in turn impair channel gating (see Scheme
II). For example, the CMS mutation  P121L decreased
ACh afﬁnity for the open state, had little effect on afﬁn-
ity for the resting closed state and markedly impaired
gating of the channel (Ohno et al., 1996). However,
similar to the present observations, the afﬁnity changes
were accompanied by a decrease in the monoliganded
gating equilibrium constant associated with occupancy
of the nonmutant    site. Furthermore, the binding
site mutations  Y190F,  Y198F,  W149F, and  Y93F all
reduced afﬁnity of ACh for closed states of the receptor
and impaired gating of the channel. For each of these
mutations, the changes in channel gating rate con-
stants were greater than changes in rate constants un-
derlying ACh binding to the resting closed state (Chen
et al., 1995; Akk et al., 1999; Akk, 2001). These studies
did not distinguish monoliganded from diliganded gat-
ing, and therefore could not separate effects on agonist
binding from those on channel gating, contrary to our
present analysis. Thus, the conclusion that the binding
site residues studied here independently affect gating
of the receptor channel may be generalized to other
key residues at the ACh binding site of the receptor.
Both  N182Y and  D175N are state speciﬁc in affect-
ing afﬁnities of closed relative to desensitized states.
 D175N preferentially affects the desensitized state be-
cause it decreases closed state afﬁnity for ACh by 17-
fold, but decreases desensitized state afﬁnity by 800-
fold.  N182Y, on the other hand, preferentially affects
the resting closed state because it increases closed state
afﬁnity by 31-fold but increases desensitized state afﬁn-
ity only 1.6-fold. Thus, the state speciﬁcity of  D175N
and  N182Y indicates that these residues, and possibly
nearby structures, contribute differently to ACh bind-
ing in one functional state compared with the other.
Studies over the past decade showed that ACh can
distinguish between the two ligand binding sites of an
individual receptor in the resting closed state, but that
the extent of the distinction depends on the species of
the receptor. For the Torpedo receptor, ACh binds with
about a 100-fold difference in afﬁnity for the two sites
in the resting closed state (Sine et al., 1990), for the fe-
tal mouse receptor the difference is 32-fold (Zhang et
al., 1995), for the adult human receptor the difference
is sixfold (Ohno et al., 1996; Wang et al., 1999), and for
the adult mouse receptor the two binding sites are in-
distinguishable (Akk and Auerbach, 1996; Wang et al.,
1997; Salamone et al., 1999). When afﬁnities of the two
binding sites are very different, a sequential description
of ACh occupancy (Scheme I) is expected to fully ac-
count for the kinetics of receptor activation at the sin-
gle channel level, as observed for receptors containing
the mutations  N182Y and  D175N.
On the other hand, for our reference wild-type hu-
man receptor, ACh occupancy should not be strictly se-
quential because the binding sites differ by only ﬁve-
fold and the underlying rate constants differ by approx-
imately twofold at the two binding sites. In such cases,
the standard alternative description of receptor activa-
tion incorporates independent binding of ACh at the
two binding sites. Occupancy is still sequential, but
there are two possible pathways for achieving double
occupancy of the resting, closed state of the receptor. A
second monoliganded state is introduced, which adds
four more rate constants for ACh binding and two
more for the second monoliganded gating step. The in-
dependent occupancy model was used to analyze single
channel dwell times from the adult mouse receptor,
which contains indistinguishable binding sites (Sala-494 CMS Mutations Alter ACh Binding and Channel Gating
mone et al., 1999). However, even in this relatively
straightforward case, constraints in ﬁtting were re-
quired in order to obtain well-deﬁned estimates of the
rate constants; the diagonal binding steps were con-
strained to be equal, as were the two monoliganded gat-
ing steps, in harmony with the observation of indistin-
guishable binding sites. For the adult human receptor,
the binding sites are measurably different and the two
monoliganded gating steps are not identical (Milone et
al., 1997), so constraining these rate constants could
not be justiﬁed. With all rate constants free to vary, our
attempts to ﬁt the independent model to single chan-
nel dwell times from the wild-type human receptor did
not yield well-deﬁned estimates of the rate constants.
Nevertheless, by combining mutagenesis of both bind-
ing sites with kinetic analyses, we estimated ACh associ-
ation and dissociation rate constants for both    and
   sites. Our results from analyses of mutations at
 N182 and the equivalent  N187 clearly show that the
site from which ACh dissociates slowly is the    site,
whereas the site from which ACh dissociates rapidly is
the    site.
Studies of the  D175N mutation in the adult mouse
receptor also revealed markedly impaired gating efﬁ-
ciency when two agonists are bound; the rate constant
for channel opening was slowed and the rate constant
for channel closing was increased (Akk et al., 1999).
The rate constant for ACh association was slowed, as we
observe, but the rate constant for ACh dissociation was
also slowed, contrary to our observed increase in the
rate of dissociation. However, contrary to our analysis,
the analysis of the mutant mouse AChR kinetics as-
Figure 7. Location of residues
 D175 and  N182 in a structural
model of the binding site interface
formed by   and   subunits of the hu-
man AChR (Sine et al., 2002). Top
panel shows the major extracellular
domain of the   subunit in magenta,
that of the   subunit in yellow and the
other subunits in gray. View is from
the periphery of the receptor normal
to the central vestibule. Bottom panel
shows a stereo view of the ligand bind-
ing site. Residue side chains are shown
in stick representation, with residues
at the center of the binding site
( W149 and  W55) and other resi-
dues mutated in CMS ( P121,  G153;
see text) shown for reference.495 Sine et al.
sumed identical binding sites, which likely spread the
effects of the mutation in the   subunit over both the
   and    binding steps.
The AChR ligand binding site is formed by pairs of
subunits:  –  and  – . Evidence that the binding sites
are formed at subunit interfaces comes from mutagen-
esis and site-directed labeling studies over the past de-
cade (Prince and Sine, 1998), and recently from struc-
tural determination of an acetylcholine binding pro-
tein homologous to the major extracellular domain of
the AChR (Brejc et al., 2001). The mutant residues
identiﬁed here are found in binding site loop G of the
  subunit, which contributes to the non-  subunit face
of the binding site and encompasses residues 161–182
(Prince and Sine, 1998). That  D175 contributes to the
binding site interface was ﬁrst demonstrated in studies
using a site-directed cross-linking reagent (Czajkowski
et al., 1993), whereas the present work is the ﬁrst dem-
onstration that  N182 contributes to the binding site.
According to a structural model of the AChR binding
site, based on lysine-scanning mutagenesis and homol-
ogy modeling (Sine et al., 2002), loop G forms an irreg-
ular coil on the outer surface of the   subunit, lodging
in a crevice formed by underlying  -strands. Loop G
approaches the   subunit face of the binding site, with
 D175 just outside the center of the binding site, which
is deﬁned by  W149 and  W55 (Fig. 7).  N182 is lo-
cated farther down loop G near the bottom of the sub-
unit, with the amide group of  N182 closely approach-
ing the main chain of the   subunit at  C128, which
forms the signature cys-loop found in all AChR sub-
units. Thus,  D175 is poised at the periphery of the
binding site interface where it can enhance entry and
suppress egress of ACh.  N182 is located below the cen-
ter of the binding site where it closely approaches the
subunit interface with the neighboring   subunit; it sta-
bilizes ACh bound to the resting closed state, most
likely through effects propagated from the subunit in-
terface to residues in loop G proximal to the binding
site. Our observation that the mutations are state-spe-
ciﬁc in altering ACh afﬁnity for resting relative to de-
sensitized states suggests that loop G harboring  N182
and  D175 rearranges in the course of receptor desen-
sitization.
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